Photo of Christopher A. Schriever

Christopher A. Schriever


Clinical Associate Professor, College of Medicine, Rockford
Clinical Associate Professor, Pharmacy Practice

Contact

Office Phone:

(815) 395-5725 (work)

Related Sites:

Teaching and Supervision Heading link

Clinical Applications (PHAR 520), 8/26/2024 – 12/6/2024
Clinical Applications (PHAR 520), 8/26/2024 – 12/6/2024
Clinical Applications (PHAR 520), 8/26/2024 – 12/6/2024
Clinical Applications (PHAR 520), 8/26/2024 – 12/6/2024
Clinical Applications (PHAR 520), 8/21/2023 – 12/1/2023
Clinical Applications (PHAR 520), 8/21/2023 – 12/1/2023
Clinical Applications (PHAR 520), 8/21/2023 – 12/1/2023
PHAR 506. Pathophysiology, Drug Action, and Therapeutics (PDAT) 6: Infectious Diseases (Phar 506), 1/9/2023 – 5/4/2023
Clinical Applications (PHAR 520), 8/22/2022 – 12/2/2022

Selected Grants

Rural-Focused Interventions to Actively Develop and Train for Rural Pharmacy Careers (RFIT), McKesson Fdn., 9/1/2024 - 8/31/2025, Obligated Amount: $283173; Anticipated Amount: $283173

ASHP Pharmacy Residency Expansion Grant Program - PGY1 2020, ASHP Research & Education Fdn., 7/1/2020 - 6/30/2021, Obligated Amount: $25000; Anticipated Amount: $25000

Reactions, attitudes, and perceptions of multidisciplinary teams during IPE outreach, Amer Assn of Colleges of Pharmacy., 9/1/2019 - 9/1/2020, Obligated Amount: $4000; Anticipated Amount: $4000

In Vitro Activity of Botanicals against Chlamydia pneumoniae isolates., National Institutes of Health., 12/2003 - Present, No Obligated Amount Set; No Anticipated Amount Set

In Vitro Activity of Botanicals against Chlamydia pneumoniae isolates., National Institutes of Health., 12/2003 - Present, No Obligated Amount Set; No Anticipated Amount Set

Metals in Exhaled Condensate as COPD Biomarker, National Institutes of Health., 10/1/2002 - 9/30/2006, No Obligated Amount Set; No Anticipated Amount Set

Metals in Exhaled Condensate as COPD Biomarker, National Institutes of Health., 10/1/2002 - 9/30/2006, No Obligated Amount Set; No Anticipated Amount Set

Development of Monoclonal Antibodies to Viral Peptides of the Mushroom Infecting La France Virus, Campbell Soup Corporation., 7/1993 - Present, No Obligated Amount Set; No Anticipated Amount Set

Immunosurveillance of Active TB by Breath Condensate, Society of Infectious Disaeses Pharmacists., Date Not Set - Present, No Obligated Amount Set; No Anticipated Amount Set

Selected Publications

Schriever, Christopher, Hays, Annette. (2023). Antimicrobial Agents. Rau’s Respiratory Care Pharmacology. Elsevier.

Schriever, Christopher, Hays, Annette. (2022). Pharmacology. First Aid Cases for the USMLE Step 1, Third Edition. McGraw Hill Professional.

Schriever, Christopher A, Danziger, Larry H. (2020). Recurrent Clostridioides difficile Infections: Should We Respond More to Toxin B?. Clinical Infectious Diseases, 71, (1), 87-88. doi:10.1093/cid/ciz814.

Ziegler, Jason, Chapman, Heather, Rueth, Megan, Hays, Annette, Schriever, Christopher, Tsaras, Geoffrey. (2020). Potential Perinatally Acquired Extended Spectrum β-Lactamase Escherichia coli Urinary Tract Infection in an Infant. The Journal of Pediatric Pharmacology and Therapeutics, 25, (3), 266-269. doi:10.5863/1551-6776-25.3.266.

Biagi, MJ, Schriever, CA, Chiampas, TD, Michienzi, SM, Patel, MC, Young, JD, Badowski, ME. (2020). Development of gynecomastia following initiation of bictegravir/emtricitabine/tenofovir alafenamide. International Journal of STD & AIDS, 31, (4), 380-382. doi:10.1177/0956462419895665.

Michienzi, Sarah M, Cai, Jiaqi, Harris, Cydnee, Kim, Sean, Patel, Nimish, Badowski, Melissa E, Chan, Juliana, Martin, Michelle T, Schriever, Christopher A. (2019). 356. HIV-HCV Coinfection: An Investigation of CD4 T-Cell Reconstitution after HCV Direct-Acting Antiviral Treatment. Open Forum Infectious Diseases, 6, (Supplement_2), s187-s187. doi:10.1093/ofid/ofz360.429.

Ahmed, Alisha, Schriever, Christopher, Britt, Nicholas, Yager, Jenna, Amin, Ronish, McGuey, Liam, Patel, Nimish. (2019). Comparing drug interaction frequencies of various hepatitis C treatment regimens among monoinfected patients. Annals of Hepatology, 18, (4), 601-606. doi:10.1016/j.aohep.2019.01.005.

Michienzi, Sarah M, Schriever, Christopher A, Badowski, Melissa E. (2019). Abacavir/lamivudine/dolutegravir single tablet regimen in patients with human immunodeficiency virus and end-stage renal disease on hemodialysis. International Journal of STD & AIDS, 30, (2), 181-187. doi:10.1177/0956462418800865.

Hemenway, Alice N, Christensen, Alyssa, Schriever, Christopher. (2018). Treatment considerations for potential uropathogens detected by precision microbiological testing. American Journal of Health-System Pharmacy, 75, (22), 1775-1782. doi:10.2146/ajhp180208.

Professional Leadership

ASHP Section Advisory Group (SAG), American Society of Health-System Pharmacists, 8/22/2022 - 12/7/2023

Spring Planning Committee, Illinois Counsel of Health-System Pharmacist, 9/1/2020 - 3/1/2021

Drug Utilization Review Board, State of Illinois, 9/5/2017 - Present

Immunization Advisory Committee, State of Illinois, 11/19/2013 - Present

Research Committee, 8/1/2011 - 8/1/2021

Education

Degrees:
Doctor of Pharmacy, University of Illinois at Chicago, United States, 1999
Master of Science, Northern Illinois University, United States, 1993
Bachelor of Science, University of Iowa, United States, 1987
Associate of Science, Rock Valley College, United States, 1985

Postgraduate Training:
Infectious Diseases Fellowship, University of Illinois at Chicago, United States, 2002
Pharmacy Practice Residency (PGY-1), VA Chicago Health System West Side and Lakeside, United States, 2000

Licensures and Certifications

Expert / Pharmacist, American Academy of HIV Medicine, 2010 - Present
National Certificate for Pharmacist, American Pharmacists Association, 11/2010 - Present
APHA Certified Immunization Trainer, American Pharmacists Association, 2012 - Present
Registered Pharmacist, State of Illinois, 9/1999 - Present